Showing 1 to 3 of 3 Clinical Trials
CLINICAL TRIAL Trial No ClinicalTrials.gov ID |
Principal Investigator
Coordinator |
||
---|---|---|---|
Lymph node oesophagus cancer
CT0075 n.d. Recruiting |
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Oesophagus |
Dr. Moishe Liberman Adeline Jouquan 514-890-8000 poste 26214 |
A Randomized, Multi-center, Double-blind, Placebo-controlled Phase 3 Study of Bemarituzumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer With FGFR2b Overexpression
FORTITUDE-101 NCT05052801 Recruiting |
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS |
Oesophagus Stomach |
Dr. Petr Kavan Aline Mamo 514-340-8222 poste 5525 |
A Phase 1b/3 Study of Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab Alone in Subjects With Previously Untreated Advanced Gastric and Gastroesophageal Junction Cancer With FGFR2b Overexpression
FORTITUDE-102 NCT05111626 Recruiting |
CHU DE QUEBEC – UNIVERSITE LAVAL
L'HOTEL-DIEU DE QUEBEC ET CRCEO |
Oesophagus Stomach |
Dr. Maxime Chénard-Poirier Maryse Gingras 418-691-5781 |